Literature DB >> 8037690

Analysis of peptidoglycan precursors in vancomycin-resistant Enterococcus gallinarum BM4174.

P E Reynolds1, H A Snaith, A J Maguire, S Dutka-Malen, P Courvalin.   

Abstract

Vancomycin resistance in enterococci is an increasing clinical problem, and several phenotypes have been identified. We demonstrate here that the resistance mechanism in the constitutively vancomycin-resistant Enterococcus gallinarum BM4174 involves an altered pathway of peptidoglycan synthesis and hydrolysis of the normal precursors in the vancomycin-sensitive pathway. A ligase encoded by the vanC gene catalyses synthesis of D-Ala-D-Ser and substitutes this dipeptide for D-Ala-D-Ala in peptidoglycan precursors. It is presumed that this substitution lowers the affinity of vancomycin for its target site. Destruction of D-Ala-D-Ala (D,D-peptidase activity) and of UDP-MurNAc-L-Ala-D-isoGlu-L-Lys-D-Ala-D-Ala by removal of the terminal D-Ala residue (D,D-carboxypeptidase activity) ensures that the normal vancomycin-sensitive pathway of peptidoglycan synthesis cannot function in the resistant strain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8037690      PMCID: PMC1137133          DOI: 10.1042/bj3010005

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  17 in total

1.  Microbial uridine-5'-pyrophosphate N-acetylamino sugar compounds. I. Biology of the penicillin-induced accumulation.

Authors:  J L STROMINGER
Journal:  J Biol Chem       Date:  1957-01       Impact factor: 5.157

2.  Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria.

Authors:  S Dutka-Malen; R Leclercq; V Coutant; J Duval; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

Review 3.  Genetics and mechanisms of glycopeptide resistance in enterococci.

Authors:  M Arthur; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

Review 4.  The structure and mode of action of glycopeptide antibiotics of the vancomycin group.

Authors:  J C Barna; D H Williams
Journal:  Annu Rev Microbiol       Date:  1984       Impact factor: 15.500

5.  Modified peptidoglycan precursors produced by glycopeptide-resistant enterococci.

Authors:  J Messer; P E Reynolds
Journal:  FEMS Microbiol Lett       Date:  1992-07-01       Impact factor: 2.742

6.  Inducible carboxypeptidase activity in vancomycin-resistant enterococci.

Authors:  L Gutmann; D Billot-Klein; S al-Obeid; I Klare; S Francoual; E Collatz; J van Heijenoort
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

7.  Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.

Authors:  M Arthur; C Molinas; F Depardieu; P Courvalin
Journal:  J Bacteriol       Date:  1993-01       Impact factor: 3.490

8.  Vancomycin resistance in Enterococcus gallinarum.

Authors:  S Vincent; P Minkler; B Bincziewski; L Etter; D M Shlaes
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

9.  Vancomycin resistance gene vanC is specific to Enterococcus gallinarum.

Authors:  R Leclercq; S Dutka-Malen; J Duval; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

10.  Modifications of the acyl-D-alanyl-D-alanine terminus affecting complex-formation with vancomycin.

Authors:  M Nieto; H R Perkins
Journal:  Biochem J       Date:  1971-08       Impact factor: 3.857

View more
  39 in total

1.  Vancomycin resistance is associated with serine-containing peptidoglycan in Enterococcus gallinarum.

Authors:  P Grohs; L Gutmann; R Legrand; B Schoot; J L Mainardi
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

Review 2.  Vancomycin-resistant enterococci.

Authors:  Y Cetinkaya; P Falk; C G Mayhall
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

3.  Structural and enzymatic characterization of BacD, an L-amino acid dipeptide ligase from Bacillus subtilis.

Authors:  Yasuhito Shomura; Emi Hinokuchi; Hajime Ikeda; Akihiro Senoo; Yuichi Takahashi; Jun-ichi Saito; Hirofumi Komori; Naoki Shibata; Yoshiyuki Yonetani; Yoshiki Higuchi
Journal:  Protein Sci       Date:  2012-03-30       Impact factor: 6.725

4.  VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis.

Authors:  Florence Depardieu; Mathias Kolbert; Hendrik Pruul; Jan Bell; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 5.  Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine.

Authors:  Peter E Reynolds; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 6.  Modes and modulations of antibiotic resistance gene expression.

Authors:  Florence Depardieu; Isabelle Podglajen; Roland Leclercq; Ekkehard Collatz; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

7.  Investigation into the functional impact of the vancomycin C-ring aryl chloride.

Authors:  Joseph R Pinchman; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2013-07-04       Impact factor: 2.823

8.  D-Ala:D-Ala ligase gene flanking the vanC cluster: evidence for presence of three ligase genes in vancomycin-resistant Enterococcus gallinarum BM4174.

Authors:  Ole-Herman Ambúr; Peter E Reynolds; Cesar A Arias
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

9.  Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.

Authors:  S Dutka-Malen; S Evers; P Courvalin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

10.  Biochemical and genetic characterization of the vanC-2 vancomycin resistance gene cluster of Enterococcus casseliflavus ATCC 25788.

Authors:  Ireena Dutta; Peter E Reynolds
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.